Key facts
- This page summarizes Erick Lucera's Form 4 filing for Editas Medicine, Inc. (EDIT).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 27 Mar 2025, 16:41.
Erick Lucera - 08 Mar 2025 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)
- Reporting relationship
- EVP, CHIEF FINANCIAL OFFICER
- Issuer ticker
- EDIT
- Reported as of
- 08 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 27 Mar 2025, 16:41:59 UTC
- Prior SEC filing
- 05 Mar 2025
- Next SEC filing
- 28 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Erick Lucera
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Erick Lucera filed Form 4 for Editas Medicine, Inc. (EDIT) on 27 Mar 2025.
Change
- Previous filing in this sequence was filed on 05 Mar 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EDIT
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +275,100
- Change %
- Price
- $0.000000
- Shares after
- 275,100
- Date
- 08 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 275,100
- Exercise price
- $1.72
- Footnotes
- F1
EDIT
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +70,000
- Change %
- Price
- $0.000000
- Shares after
- 70,000
- Date
- 08 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 70,000
- Exercise price
- $1.72
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Erick Lucera is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029.
Footnote F2
This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026.